Trial Profile
Comparing the effects of Celecoxib with placebo on inflammatory factors and cognitive impairment in mood disorder patients undergoing electroconvulsive therapy (ECT)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Bipolar disorders; Depressive disorders
- Focus Biomarker; Pharmacodynamics
- 17 Apr 2012 New trial record